Search research articles
Contact Us
Filters
Showing results (451-460 of 482) with videos related to
Page
of 49
Sort By:
Hemasphere
|
March 24, 2025
Long-term results of the FIL MCL0208 trial of lenalidomide maintenance versus observation after ASCT in MCL patients
Rita Tavarozzi, Simone Ferrero, Andrea Evangelista, et al.
Hemasphere
|
December 10, 2025
The role of time to first progression and fitness status in elderly patients with mantle cell lymphoma: Results from the ELDERLY MANTLE-FIRST study
Francesca Maria Quaglia, Annalisa Arcari, Lucia Morello, et al.
Haematologica
|
September 21, 2019
<i>KMT2D</i> mutations and <i>TP53</i> disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study
Simone Ferrero, Davide Rossi, Andrea Rinaldi, et al.
Leukemia
|
November 3, 2025
Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trial
Mouhamad Khouja, Elisa Genuardi, Simone Ferrero, et al.
Oncotarget
|
May 29, 2018
Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma
Alessandro Broccoli, Beatrice Casadei, Alice Morigi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 28, 2021
Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study
Stefano Luminari, Martina Manni, Sara Galimberti, et al.
Hemasphere
|
January 25, 2020
MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL)
Maria Chiara Tisi, Simone Ferrero, Irene Dogliotti, et al.
British Journal of Haematology
|
May 14, 2026
Development and validation of a novel prognostic index for mantle cell lymphoma integrating TP53 mutations (MIPI53)
Miguel Bastos-Boente, Alejandro Medina-Herrera, Almudena Navarro-Bailón, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 2, 2018
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi
Jacopo Olivieri, Federico Mosna, Matteo Pelosini, et al.
Cell Reports. Medicine
|
December 30, 2020
ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare Disorder
Sheila K Pierson, Johnson S Khor, Jasira Ziglar, et al.
Page
of 49
Search research articles
Search
Showing results (451-460 of 482) with videos related to
Sort By:
Page
of 49
Hemasphere
|
March 24, 2025
Long-term results of the FIL MCL0208 trial of lenalidomide maintenance versus observation after ASCT in MCL patients
Rita Tavarozzi, Simone Ferrero, Andrea Evangelista, et al.
Hemasphere
|
December 10, 2025
The role of time to first progression and fitness status in elderly patients with mantle cell lymphoma: Results from the ELDERLY MANTLE-FIRST study
Francesca Maria Quaglia, Annalisa Arcari, Lucia Morello, et al.
Haematologica
|
September 21, 2019
<i>KMT2D</i> mutations and <i>TP53</i> disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study
Simone Ferrero, Davide Rossi, Andrea Rinaldi, et al.
Leukemia
|
November 3, 2025
Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trial
Mouhamad Khouja, Elisa Genuardi, Simone Ferrero, et al.
Oncotarget
|
May 29, 2018
Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma
Alessandro Broccoli, Beatrice Casadei, Alice Morigi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 28, 2021
Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study
Stefano Luminari, Martina Manni, Sara Galimberti, et al.
Hemasphere
|
January 25, 2020
MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL)
Maria Chiara Tisi, Simone Ferrero, Irene Dogliotti, et al.
British Journal of Haematology
|
May 14, 2026
Development and validation of a novel prognostic index for mantle cell lymphoma integrating TP53 mutations (MIPI53)
Miguel Bastos-Boente, Alejandro Medina-Herrera, Almudena Navarro-Bailón, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 2, 2018
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi
Jacopo Olivieri, Federico Mosna, Matteo Pelosini, et al.
Cell Reports. Medicine
|
December 30, 2020
ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare Disorder
Sheila K Pierson, Johnson S Khor, Jasira Ziglar, et al.
Page
of 49